Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Formulations of GLP-1 with extended duration The enzyme DPP-4 is responsible for the rapid inactivation of GLP-1, although some GLP-1 is also removed from the circulation by renal clearance and by the enzyme neutral endopeptidase [11]
10.1021/acsbiomedchemau.1c00062 24 KimK.AnA.ParkH
Despite ongoing advancements in coronary revascularization and secondary prevention strategies, up to 20% of ACS patients experience recurrent myocardial infarction (MI) within five years after the index event [2,3,3,4,], due to either stent failure or progression of native coronary artery disease (CAD) in non-treated segments [5]
These cells were grown in RPMI 1640 media provided with 10% fetal bovine serum, 1% penicillin, and 1% streptomycin, and then incubated with 5% CO 2 at 37C
![Cardiovascular disease continuum-GLP-1 action. Adapted from [46]](https://www.researchgate.net/publication/357072789/figure/fig1/AS:1146405179654167@1650335702879/Cardiovascular-disease-continuum-GLP-1-action-Adapted-from-46.png)
